Navigating the EMVS Towards 2030: Driving Evolution, Strengthening Resilience and Preparing for What's Next
The European Medicines Verification System (EMVS) is entering a new phase of maturity and evolution. As the pharmaceutical landscape continues to evolve, the EMVS must adapt to changing regulatory requirements, technological developments and emerging supply chain needs.
This session will provide an overview of the strategic priorities and key initiatives shaping the next phase of EMVS evolution, focusing on resilience, operational excellence, regulatory readiness and stakeholder collaboration.
Participants will gain insights into how the EMVS community is working together to ensure that Europe's medicines verification ecosystem remains secure, effective and fit for the future.
Sonia Queiros
Chief Operating Officer at European Medicines Verification Organisation